Professor Lorraine Harper: Clinical Trials

1 trial sponsored by Professor Lorraine Harper, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow Professor Lorraine Harper: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CMV Modulation of the Immune System in ANCA-associated Vasculitis
Valaciclovir - ANCA Associated Vasculitis, CMV Infection
Phase 2UnknownProfessor Lorraine Harper382013-07-012016-11-30

Conditions studied

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Cytomegalovirus Infections (1)

Interventions

Valacyclovir (1)

Countries

United Kingdom (1)

Top investigators

Lorraine Harper, MRCP PhD (1)

Results publications

PMID 26312852, PMID 27450392, PMID 30102389